BAP1 Loss Defines a Pathologically Aggressive Subgroup of Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Kapur, P. [1 ]
Christie, A. [1 ]
Pena-Llopis, S. [1 ]
Margulis, V. [1 ]
Lotan, Y. [1 ]
Xie, X-J [1 ]
Brugarolas, J. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
926
引用
收藏
页码：223A / 223A
页数：1
相关论文
共 50 条
  • [41] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Eckel-Passow, Jeanette E.
    Serie, Daniel J.
    Cheville, John C.
    Ho, Thai H.
    Kapur, Payal
    Brugarolas, James
    Thompson, R. Houston
    Leibovich, Bradley C.
    Kwon, Eugene D.
    Joseph, Richard W.
    Parker, Alexander S.
    BMC UROLOGY, 2017, 17 : 1 - 7
  • [42] Prognostic value of BAP1 expression in clear cell renal cell carcinoma with inferior vena cava tumor thrombosis.
    Oka, Suguru
    Inoshita, Naoko
    Miura, Yuji
    Oki, Ryosuke
    Miyama, Yu
    Nagamoto, Shoichi
    Ogawa, Kohei
    Sakaguchi, Kazushige
    Kondoh, Chihiro
    Kurosawa, Kazuhiro
    Urakami, Shinji
    Takano, Toshimi
    Okaneya, Toshikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis
    Oka, Suguru
    Inoshita, Naoko
    Miura, Yuji
    Oki, Ryosuke
    Miyama, Yu
    Nagamoto, Shoichi
    Ogawa, Kohei
    Sakaguchi, Kazushige
    Kondoh, Chihiro
    Kurosawa, Kazuhiro
    Urakami, Shinji
    Takano, Toshimi
    Okaneya, Toshikazu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 365.e9 - 365.e14
  • [44] BAP1 loss confers sensitivity to bromodomain and extra-terminal inhibitors in renal cell carcinoma
    Shi, Wen-hui
    Liu, Xiao-lian
    Zhou, Run-hua
    Zhang, Gui-ming
    Chen, Liang
    Zhou, Yan-ling
    Jin, Xuan-yu
    Yu, Le
    Li, Yi-lei
    ANTI-CANCER DRUGS, 2024, 35 (10) : 932 - 942
  • [45] Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations
    Mochel, Mark C.
    Pins, Adriano
    Nose, Vania
    Hoang, Mai P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (06) : 901 - 904
  • [46] BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma
    Langbein, Lauren E.
    El Hajjar, Rayan
    He, Shen
    Sementino, Eleonora
    Zhong, Zhijiu
    Jiang, Wei
    Leiby, Benjamin E.
    Li, Li
    Uzzo, Robert G.
    Testa, Joseph R.
    Yang, Haifeng
    CANCER LETTERS, 2022, 547
  • [47] Germline BAP1 Mutation in Patients with Uveal Melanoma and Renal Cell Carcinoma
    Shao, Yusra Fatima
    DeBenedictis, Meghan J.
    Yeaney, Gabrielle
    Singh, Arun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [48] Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens
    Minardi, Daniele
    Lucarini, Guendalina
    Milanese, Giulio
    Montironi, Rodolfo
    Di Primio, Roberto
    VIRCHOWS ARCHIV, 2017, 471 (01) : 99 - 105
  • [49] Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens
    Daniele Minardi
    Guendalina Lucarini
    Giulio Milanese
    Rodolfo Montironi
    Roberto Di Primio
    Virchows Archiv, 2017, 471 : 99 - 105
  • [50] Germ Line BAP1 Mutation in Patients with Uveal Melanoma and Renal Cell Carcinoma
    Shao, Yusra F.
    DeBenedictis, Meghan
    Yeaney, Gabrielle
    Singh, Arun D.
    OCULAR ONCOLOGY AND PATHOLOGY, 2021, 7 (05) : 340 - 345
12345